OMX30 1 470 -0,5%  OMXH25 3 462 -0,6%  OMXC20 828 -0,1%  Dow 19 170 -0,1%  Nas 4 739 0,1%  EUR 9,7994 -0,4%  USD 9,1889 0,0%  Olja 54,2 0,0%  Guld 1 178 1,4% 

Becton, Dickinson & Aktie

165,52USD 0,85USD 0,52%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Becton, Dickinson &

2016 2017e 2018e 2019e 2020e
Utdelning 2,64 2,91 3,09 3,67 4,26
Direktavkastning (i %) 1,48 1,76 1,87 2,22 2,58
PE-tal 20,73 17,38 15,74 14,39 12,90
Resultat/aktie 8,59 9,49 10,48 11,46 12,79

Nyheter om Becton, Dickinson & Co. (BD)

Inga nyheter tillgängliga
ytterligare nyheter

Analyser om Becton, Dickinson & Co. (BD)

ytterligare analyser

Becton, Dickinson & Peer Group

Becton, Dickinson & 165,52
0,5%
CR Bard 209,95
1,5%
Fresenius Medical Care 72,63
0,4%
Fresenius 66,98
0,1%
STRATEC Biomedical 43,00
3,7%
Thermo Fisher Scientific 141,89
1,6%
pagehit

Inloggning krävs

Användarnamn (e-post):
Lösenord:
Logga in

För att använda myFinans funktioner måste du vara inloggad. Om du inte har något användarkonto hos VA Finans kan du registrera dig här utan kostnad.

Lägg till instrument

Vad tycker du?

Profil Becton, Dickinson & Co. (BD)

till bolagsprofilen
Becton, Dickinson & Co. is a global medical technology company. The company is engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The company operates through two worldwide business segments: BD Medical and BD Life Sciences. The BD Medical segment produces medical devices that are used in healthcare settings. This segment product includes needles, syringes and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles for the self-injection of insulin and other drugs used in the treatment of diabetes. The BD Life Sciences segment produces products for the safe collection and transport of diagnostic specimens, as well as instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The segment also produces research and clinical tools that facilitate the study of cells, and the components of cells, to gain a better understanding of normal and disease processes. The principal products and services in the Life Sciences segment include integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing and tuberculosis culturing systems; molecular testing systems for infectious diseases and women's health; microorganism identification and drug susceptibility systems; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation; plated media; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunology and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. Becton, Dickinson & Co. was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Realtidskurs Becton, Dickinson & Co. (BD)

Bid
165,47
USD
Ask
165,51
USD
Kurstid
22:00
Börsen BTT

Aktiekurs Becton, Dickinson & Co. (BD) i USDPUSH CHART

Kurs 165,52 USD 0,85 0,52 %
Kurstid 22:00:00
Datum 02.12.2016
Öppning 165,30
Gårdagen 165,52
Dagshögsta 167,32
Dagslägsta 164,81
52 v. högsta 181,69
52 v. lägsta 129,50
52 v. perf.
Volym (Antal) 37 782
Börsvärde (SEK) 323,14 Mrd
Börsen
Kurs för 165,52 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 1 520,95 SEK.

Till aktien Becton, Dickinson &

Ticker
ISIN US0758871091
Index S&P 500

Becton, Dickinson & Nyckeltal

Börsvärde i SEK 323,14 Mrd
Free float % 99,42
Antal aktier mio. 212,32
Cashflow/aktie i lokal valuta 10,26
Bokvärde/aktie i lokal valuta 37,97
60 dagar vola 23,27
PBV 4,69

Becton, Dickinson & Historiska kurser

2016-12-01 164,67 47 079
2016-11-30 169,14 47 751
2016-11-29 172,72 53 664
2016-11-28 170,30 30 272
2016-11-25 170,56 21 505

Aktier i samma industri med bättre 1 års perf.

SIGA Technologies Inc. 455,2 %
Merge Healthcare Inc Cash Settlement At USD 7.13 A Sh 219,3 %
Exelixis Inc. 202,7 %
Pharmacyclics Inc 198,2 %
CV Therapeutics Inc. 169,1 %